% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Cardoso:274169,
      author       = {R. Cardoso$^*$ and M. Hoffmeister$^*$ and H. Brenner$^*$},
      title        = {{B}reast cancer screening programmes and self-reported
                      mammography use in {E}uropean countries.},
      journal      = {International journal of cancer},
      volume       = {152},
      number       = {12},
      issn         = {0020-7136},
      address      = {Bognor Regis},
      publisher    = {Wiley-Liss},
      reportid     = {DKFZ-2023-00471},
      pages        = {2512-2527},
      year         = {2023},
      note         = {#EA:C120#LA:C070#LA:C120# / 2023 Jun 15;152(12):2512-2527},
      abstract     = {Mammography screening has been shown to be able to reduce
                      breast cancer mortality, leading most European countries to
                      implement mammography-based screening programmes. In this
                      study, we analysed key characteristics of breast cancer
                      screening programmes and mammography use in European
                      countries. Information on screening programmes were obtained
                      from the 2017 European Union screening report, websites from
                      governments and cancer registries, and through literature
                      search in PubMed (studies published up to June 20, 2022).
                      Data on self-reported mammography use in the past two years
                      were obtained from Eurostat, and had been derived from the
                      European Health Interview Survey (cross-sectional survey),
                      conducted in the 27 European Union countries, Iceland,
                      Norway, Serbia, Turkey, and the UK in 2013-2015 and
                      2018-2020. Data were analysed for each country according to
                      their human development index (HDI). By 2022, all included
                      countries besides Bulgaria and Greece had introduced an
                      organised mammography-based screening programme; Romania and
                      Turkey had only pilot programmes. Screening programmes
                      differ substantially across countries, particularly in
                      timing of implementation (e.g., in Sweden, the Netherlands
                      before 1990; Belgium, France between 2000 and 2004; Denmark,
                      Germany between 2005 and 2009; Austria, Slovakia after
                      2010). Self-reported mammography use also differed
                      considerably across countries, and went along with HDI -
                      from $<36\%$ in all countries with HDI <0.85 to $>70\%$ in
                      most countries with HDI >0.90. The data call for efforts to
                      improve mammography screening use across Europe,
                      particularly in countries with lower development levels
                      where breast cancer mortality rates are also among the
                      highest in the region. This article is protected by
                      copyright. All rights reserved.},
      keywords     = {Breast cancer screening (Other) / Europe (Other) / HDI
                      (Other) / mammography (Other) / utilisation (Other)},
      cin          = {C120 / C070 / HD01},
      ddc          = {610},
      cid          = {I:(DE-He78)C120-20160331 / I:(DE-He78)C070-20160331 /
                      I:(DE-He78)HD01-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:36883419},
      doi          = {10.1002/ijc.34494},
      url          = {https://inrepo02.dkfz.de/record/274169},
}